Dedicated outpatient vascular access center decreases hospitalization and missed outpatient dialysis treatments

Kidney International

Volumn 69, Issue 2, 2006, Pages 393-398

  Mishler, R ^a,c   Sands, J J ^b   Ofsthun, N J ^b   Teng, M ^b   Schon, D ^a   Lazarus, J M ^b  

^a Arizona Kidney Disease and Hypertension Surgery Center   (United States)

^b FRESENIUS MEDICAL CARE NORTH AMERICA   (United States)

^c AKDHC ASC   (United States)

Author keywords

Arteriovenous fistula; Dialysis access; Hemodialysis; Interventional nephrology; Polytetrafluoroethylene graft; Vascular access center

Indexed keywords

ARTICLE; DIALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; HEALTH CARE FACILITY; HOSPITALIZATION; HUMAN; MEDICAL CARE; MEDICAL STAFF; NEPHROLOGIST; OUTPATIENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; VASCULAR ACCESS;

ADULT; AGED; AMBULATORY CARE; ARTERIOVENOUS SHUNT, SURGICAL; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 33644649147     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000066     Document Type: Article

References (17)

1. US Renal Data System. USRDS 2003 Annual Data Report. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD, 2003.
2. Eggers PW. PhD NIDDK from Presentation at Cincinnati Hemodialysis Vascular Access Symposium 2004, vol. 20, Cincinnati, OH, 2004.
3. Asif A, Byers P, Vieira CF et al. Developing a comprehensive diagnostic and interventional nephrology program at an academic center. Am J Kidney Dis 2003; 42(2): 229-233.
4. Rasmussen RL. Establishing an interventional nephrology suite. Semin Nephrol 2002; 22(3): 237-241.
5. Saad T. Training, certification, and reimbursement for nephrology procedures. Semin Nephrol 2002; 22(3): 276-285 (review).
6. Beathard GA. The treatment of vascular access graft dysfunction: a nephrologist's view and experience. Adv Ren Replace Ther 1994l; 1(2): 131-147.
7. Beathard GA. Management of complications of endovascular dialysis access procedures. Semin Dial 2003; 16(4): 309-313.
8. Schon D, Mishler R. Pharmacomechanical thrombolysis of natural vein fistulas: reduced dose of TPA and long-term follow-up. Semin Dial 2003; 16(3): 272-275.
9. Schon D, Mishler R. Salvage of occluded autologous arteriovenous fistulae. Am J Kidney Dis 2000; 36(4): 804-810.
10. Held PJ, Port FK, Wolfe RA et al. The dose of hemodialysis and patient mortality. Kidney Int 1996; 50(2): 550-556.
11. Medicare Program Changes to the Hospital Outpatient Prospective Payment System and Calendar Year 2005 Prospective Payment Rates. Center For Medicare and Medicaid Services, 42 CFR Part 419, Federal Register V 69 N219 November 15, 2004.
12. Medicare Program Changes to the Hospital Inpatient Prospective Payment System and Fiscal Year 2005 Prospective Payment Rates. Center For Medicare and Medicaid Services, 42 CFR Part 403, 413, 418, 460, 482, 483, 485, 489, CMS 1428-F.
13. Pisoni RL, Young EW, Dykstra DW et al. Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int 61; 2002: 305-316.
14. Dhingra RK, Young EW, Hulbert-Shearon TE et al. Type of vascular access and mortality in US hemodialysis patients. Kidney Int 2001;60:1443-1451.
15. Sands JJ, Perry MA. Where are all the AV fistulas? Semin Dial 2002; 15(3): 146-148.
16. Lee H, Manns B, Taub K et al. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis 2002; 40(3 September): 611-622.
17. K/DOQI Clinical Practice Guidelines for Vascular Access 2000; National Kidney Foundation. Am J Kidney Dis 2001; 37(Suppl 1): S137-S181.